Nucleoside Analog Antiviral [EPC]
8 drugs in this class with 200,941 total adverse event reports.
8 Drugs
200,941 Total Reports
29,376 Serious Reports
17,970 Death Reports
| # | Drug Name | Generic Name | Reports | Serious | Deaths |
|---|---|---|---|---|---|
| 1 | Ribavirin | RIBAVIRIN | 63,877 | 4,412 | 3,399 |
| 2 | Peginterferon Alfa-2a | PEGINTERFERON ALFA-2A | 53,689 | 2,753 | 1,797 |
| 3 | Sofosbuvir | SOFOSBUVIR | 19,611 | 2,221 | 1,798 |
| 4 | Ledipasvir / Sofosbuvir | LEDIPASVIR AND SOFOSBUVIR | 19,106 | 1,145 | 776 |
| 5 | Velpatasvir / Sofosbuvir | VELPATASVIR AND SOFOSBUVIR | 12,698 | 3,113 | 576 |
| 6 | Regorafenib | REGORAFENIB | 11,442 | 4,943 | 2,347 |
| 7 | Trifluridine / Tipiracil | TRIFLURIDINE AND TIPIRACIL | 10,494 | 5,148 | 4,196 |
| 8 | Ganciclovir | GANCICLOVIR | 10,024 | 5,641 | 3,081 |